XML 107 R91.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity-Based Compensation - Restricted Stock Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Feb. 09, 2019
Apr. 02, 2018
Feb. 09, 2018
Feb. 03, 2017
Feb. 03, 2016
Dec. 21, 2015
May 26, 2015
Dec. 31, 2015
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Allocated share-based compensation expense                 $ 50.9 $ 18.9 $ 12.4  
Accelerated share-based compensation                 6.9 $ 1.3    
Compensation cost not yet recognized                 $ 40.9      
Compensation cost not yet recognized, period for recognition                 1 year 7 months      
Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Outstanding shares (in shares)               3,900,000 2,077,265 1,581,711 2,908,374  
Shares granted in period (in shares)     772,642     318,000     1,146,586 982,764 844,646  
Vested in period, weighted average grant date fair value (in dollars per share)                 $ 34.90      
Grants in period, weighted average grant date fair value (in dollars per share)         $ 45.85 $ 32.37     $ 46.27 $ 38.31 $ 28.56  
Vesting period (in years)     3 years     3 years            
The Omnibus Plan | Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Outstanding shares (in shares)                 3,596,344      
The Omnibus Plan | Restricted Stock | Directors                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Accelerated vesting, number of shares               4,381,021        
BKLS LLC Profit Interests Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares converted (in shares)             (10,733,330)          
Vested in period, weighted average grant date fair value (in dollars per share)                   $ 2.01    
Grants in period, weighted average grant date fair value (in dollars per share)                     $ 2.10  
Vesting period (in years)                       3 years
Common Class A | The Omnibus Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares authorized                     11,000,000.0  
Additional shares authorized (in shares)                   7,500,000.0    
Common Class A | The Omnibus Plan | Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares converted (in shares)             7,994,215          
Subsequent Event | Common Class A | The Omnibus Plan | Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares granted in period (in shares) 793,863                      
Grants in period, weighted average grant date fair value (in dollars per share) $ 52.38                      
Vesting after third year | Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares granted in period (in shares)   200,427   203,160 552,311              
Grants in period, weighted average grant date fair value (in dollars per share)       $ 37.90                
Vesting period (in years)   2 years 3 months 19 days   3 years 4 years              
Vesting after second year | Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares granted in period (in shares)   159,915   681,410 247,437              
Grants in period, weighted average grant date fair value (in dollars per share)   $ 46.90     $ 28.29              
Vesting period (in years)   3 years   4 years 3 years